Parenchyma Priority Approach
Parenchyma Priority Approach - Related Videos
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
0 Views •
Cited by 40 •
2018
This manuscript describes the Research Prioritization by Affected Communities (RPAC) protocol and findings from its use with women at risk for preterm birth. Using the protocol, women identified and prioritized their unanswered questions about pregnancy, birth and neonatal care aimed at influencing research priority setting by funders and researchers.
13:57
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
0 Views •
2025
This protocol involves a laparoscopic anatomical resection of liver segment VII with liver parenchymal transection following a priority approach. This technique is unaffected by anatomical variations.
06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
0 Views •
Cited by 7 •
2020
A protocol to enable individuals with developmental language disorder (DLD) and their parents/carers to meaningfully participate in a research priority setting exercise is established. The protocol includes a defined program of activities for data collection, and methods to incorporate this data into the broader research priority setting process.
05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
0 Views •
2025
To evaluate the clinical benefits of laparoscopic right hemihepatectomy via the in situ anterior approach, emphasizing its advantages in minimizing tumor dissemination risks, reducing bleeding, and enhancing surgical safety, particularly for complex liver tumors.
06:40
Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma
0 Views •
Cited by 2 •
2022
Intensive preparation of intact mouse cerebral endothelial "tubes" from cerebral parenchymal arterioles is illustrated for studying cerebral blood flow regulation. Further, we demonstrate the experimental strengths of this endothelial study model for fluorescence imaging and electrophysiology measurement of key cellular signaling pathways, including changes in intracellular [Ca2+] and membrane potential.
FAQs
The assessment compares abnormal findings with the surrounding parenchyma’s structure and function. Tissue that remains preserved can provide an important contrast to diseased areas, while changes that disrupt both appearance and function may carry greater significance. This comparison helps clinicians interpret abnormalities in context rather than treating every finding as equivalent or assuming that all tissue within an organ is similarly affected.
Each feature contributes different information about the clinical situation. Structure shows how tissue is organized, function indicates whether it remains operational, and the relationship between parenchyma and an abnormal finding places that finding in context. Considering these elements together supports more precise interpretation of imaging and pathology and reduces the risk that an isolated observation will determine planning without regard to preserved organ tissue.
Treatment planning weighs the need to control disease against the amount of functional parenchyma that may be lost or disturbed. A more disruptive intervention may affect preserved tissue, whereas a tissue-sparing option may better maintain function when clinically appropriate. This balance makes functional preservation an explicit part of decision-making rather than an issue considered only after treatment has been selected.
Imaging can characterize tissue distribution and the relationship between an abnormality and surrounding parenchyma, while pathology can provide tissue-based characterization. Using both perspectives helps connect anatomical findings with tissue assessment. The approach therefore supports interpretation that is organized around the condition of the organ tissue and its functional implications, rather than relying on one information source in isolation.
First, clinicians characterize the relevant parenchyma by assessing its structure and function. Next, they examine how abnormal findings relate to that tissue and distinguish affected areas from preserved regions. They then compare possible interventions according to disease-control needs and potential disruption of functional tissue. The resulting plan can incorporate tissue-sparing treatment, targeted sampling, or structured follow-up.
Targeted sampling is useful when tissue characterization and the relationship between an abnormal finding and surrounding parenchyma indicate that selected areas may provide the most relevant information. Focusing the sample can support more precise assessment while limiting unnecessary disruption to preserved tissue. Its role is therefore linked to anatomical and functional interpretation, not simply to the presence of an abnormality.
Follow-up can remain focused on changes in both abnormal findings and the condition of the surrounding parenchyma. Clinicians may use this perspective to assess whether disease-related features persist, whether functional tissue remains preserved, and whether management should be reconsidered. In this way, follow-up connects ongoing anatomical assessment with functional preservation and patient-centered decisions over time.